Raghuram Koganti

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Venues

Science advances

Bioengineering (Basel, Switzerland)

Pharmaceutics

Life (Basel, Switzerland)

University of Illinois at Chicago (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Illinois at Chicago Aug 20 2017 - May 08 2020

United States

BSC :: Department of Economics

Publications

Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Mohammad Soleimani, Kasra Cheraqpour, Raghuram Koganti, Seyed Mahbod Baharnoori, Ali R Djalilian
Concise Review: Bioengineering of Limbal Stem Cell Niche. Bioengineering (Basel, Switzerland) 10 (1) (2023)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Mohammad Soleimani, Kasra Cheraqpour, Reza Sadeghi, Saharnaz Pezeshgi, Raghuram Koganti, Ali R Djalilian
Artificial Intelligence and Infectious Keratitis: Where Are We Now? Life (Basel, Switzerland) 13 (11) (2023)
Mohammad Soleimani, Kasra Cheraqpour, Raghuram Koganti, Seyed Mahbod Baharnoori, Ali R Djalilian
Concise Review: Bioengineering of Limbal Stem Cell Niche. Bioengineering (Basel, Switzerland) 10 (1) (2023)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Seungwon An, Khandaker Anwar, Mohammadjavad Ashraf, Hyungjo Lee, Rebecca Jung, Raghuram Koganti, Mahmood Ghassemi, Ali R Djalilian
Wound-Healing Effects of Mesenchymal Stromal Cell Secretome in the Cornea and the Role of Exosomes. Pharmaceutics 15 (5) (2023)
Seungwon An, Xiang Shen, Khandaker Anwar, Mohammadjavad Ashraf, Hyungjo Lee, Raghuram Koganti, Mahmood Ghassemi, Ali R Djalilian
Therapeutic Potential of Mesenchymal Stem Cell-Secreted Factors on Delay in Corneal Wound Healing by Nitrogen Mustard. International journal of molecular sciences 23 (19) (2022)
Yogesh Sutar, Tejabhiram Yadavalli, Sagar Kumar Paul, Sudipta Mallick, Raghuram Koganti, Harsh Chauhan, Abhijit A Date, Deepak Shukla
BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2. Pharmaceutics 13 (11) (2021)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alexander Agelidis, Raghuram Koganti, Joshua M Ames, Lulia Koujah, Tejabhiram Yadavalli, Krishnaraju Madavaraju, Lisa M Shantz, Deepak Shukla
mTORC2 confers neuroprotection and potentiates immunity during virus infection. Nature communications 12 (1) (2021)
Chandrashekhar D Patil, Rahul K Suryawanshi, Joshua M Ames, Raghuram Koganti, Alex Agelidis, Divya Kapoor, Tejabhiram Yadavalli, Lulia Koujah, Henry C Tseng, Deepak Shukla
Intrinsic Antiviral Activity of Optineurin Prevents Hyperproliferation of a Primary Herpes Simplex Virus Type 2 Infection. Journal of immunology (Baltimore, Md. : 1950) (2021)
Tejabhiram Yadavalli, Rahul Suryawanshi, Raghuram Koganti, James Hopkins, Joshua M Ames, Lulia Koujah, Aqsa Iqbal, Krishnaraju Madavaraju, Alex Agelidis, Deepak Shukla
Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing. Science advances 6 (49) (2020)

Raghuram Koganti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Raghuram Koganti